Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 161 - 180 results of 2,494 for search '(( significant progress decrease ) OR ( significant ((step decrease) OR (nn decrease)) ))', query time: 0.59s Refine Results
  1. 161
    The Laboratory Animal Flow Diagram.

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  2. 162
    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).

    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  3. 163
    The trends of gene expression in the metabolism of triglycerides in liver tissue.

    The trends of gene expression in the metabolism of triglycerides in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  4. 164
    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.

    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  5. 165
    The trends of cholesterol metabolism-related gene expression in liver tissue.

    The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  6. 166
    <sup>1</sup>H NMR spectra for kylo-0603.

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  7. 167
    Kylo-0603’s EC50 & tissue levels.

    Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  8. 168
    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.

    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  9. 169
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  10. 170
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  11. 171
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  12. 172
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  13. 173
    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.

    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  14. 174
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  15. 175
    <sup>13</sup>C NMR spectra for Kylo-0603.

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  16. 176
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  17. 177
    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603 (0.1–10 mg/kg/day, as indicated).

    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  18. 178
    DIO Mice Liver Staining.

    DIO Mice Liver Staining. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  19. 179
    Trends of peroxisome-related gene expression in liver tissue.

    Trends of peroxisome-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  20. 180
    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).

    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:

Search Tools: